These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 32723108)

  • 21. Mucous membrane pemphigoid-otorhinolaryngological manifestations: a retrospective cohort study.
    Madgar O; Baniel A; Yarom N; Glikson E; Zeeli T; Sprecher E; Alon EE
    Eur Arch Otorhinolaryngol; 2020 Mar; 277(3):939-945. PubMed ID: 31980882
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pemphigus and mucous membrane pemphigoid: An update from diagnosis to therapy.
    Buonavoglia A; Leone P; Dammacco R; Di Lernia G; Petruzzi M; Bonamonte D; Vacca A; Racanelli V; Dammacco F
    Autoimmun Rev; 2019 Apr; 18(4):349-358. PubMed ID: 30738958
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Biologic treatment outcomes in mucous membrane pemphigoid: A systematic review.
    Lytvyn Y; Rahat S; Mufti A; Witol A; Bagit A; Sachdeva M; Yeung J
    J Am Acad Dermatol; 2022 Jul; 87(1):110-120. PubMed ID: 33422625
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Rituximab as Induction Therapy in Eosinophilic Granulomatosis with Polyangiitis Refractory to Conventional Immunosuppressive Treatment: A 36-Month Follow-Up Analysis.
    Thiel J; Troilo A; Salzer U; Schleyer T; Halmschlag K; Rizzi M; Frede N; Venhoff A; Voll RE; Venhoff N
    J Allergy Clin Immunol Pract; 2017; 5(6):1556-1563. PubMed ID: 28916432
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Single Center Retrospective Study of Patients with Ocular Mucous Membrane Pemphigoid (MMP).
    Morel M; DeGrazia T; Ward L; Behshad S; Kim HJ; Feldman R
    Ocul Immunol Inflamm; 2022 Jan; 30(1):256-261. PubMed ID: 32835566
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Positive clinical outcome in a patient with recalcitrant bullous pemphigoid treated with rituximab and intravenous immunoglobulin.
    Nguyen T; Ahmed AR
    Clin Exp Dermatol; 2017 Jul; 42(5):516-519. PubMed ID: 28508388
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The role of intravenous immunoglobulin in treatment of mucous membrane pemphigoid: A review of literature.
    Tavakolpour S
    J Res Med Sci; 2016; 21():37. PubMed ID: 27904583
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pemphigoid of the pulmonary system (POPS): A review of a less recognized feature.
    Ahmed AR; Aksoy M; Kinane TB
    Autoimmun Rev; 2022 Nov; 21(11):103180. PubMed ID: 35981700
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Autoimmune Subepidermal Bullous Diseases of the Skin and Mucosae: Clinical Features, Diagnosis, and Management.
    Amber KT; Murrell DF; Schmidt E; Joly P; Borradori L
    Clin Rev Allergy Immunol; 2018 Feb; 54(1):26-51. PubMed ID: 28779299
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Dual diagnosis of Pemphigus and pemphigoid. Retrospective review of thirty cases in the literature.
    Sami N; Ahmed AR
    Dermatology; 2001; 202(4):293-301. PubMed ID: 11455140
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Comparison of rituximab and intravenous immunoglobulin in the treatment of autoimmune bullous diseases: Real-life data from a single centre.
    Huseynova Terzi L; Akdogan N; Dogan Gunaydin S; Atakan N
    Int J Clin Pract; 2021 Dec; 75(12):e14955. PubMed ID: 34610193
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Efficacy of rituximab in resistant palindromic rheumatism: first report in literature.
    Raghavan P; Sreenath S; Cherian S; Shenoy PD
    Clin Rheumatol; 2019 Sep; 38(9):2399-2402. PubMed ID: 31076945
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A prospective study comparing patients with early and late relapsing pemphigus treated with rituximab.
    Saleh MA
    J Am Acad Dermatol; 2018 Jul; 79(1):97-103. PubMed ID: 29408700
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Retrospective single-arm cohort study of steroid-dependent minimal change nephrotic syndrome treated with very low-dose rituximab.
    Fujimoto K; Kagaya Y; Kumano S; Fujii A; Tsuruyama Y; Matsuura T; Yamazaki K; Nomura K; Okada K; Okino K; Adachi H; Furuichi K; Yokoyama H
    Clin Nephrol; 2021 Jan; 95(1):29-36. PubMed ID: 33074094
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Comparing early and late treatments with rituximab in pemphigus vulgaris: which one is better?
    Balighi K; Daneshpazhooh M; Mahmoudi H; Badakhsh M; Teimourpour A; Ehsani AH; Azizpour A; Akbari Z; Mahdavinia M; Ghasemiadl M; Tavakolpour S
    Arch Dermatol Res; 2019 Jan; 311(1):63-69. PubMed ID: 30506422
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Efficacy and Safety of Rituximab in Korean Patients with Refractory Inflammatory Myopathies.
    Ahn GY; Suh CH; Kim YG; Park YB; Shim SC; Lee SH; Lee SS; Bae SC; Yoo DH
    J Korean Med Sci; 2020 Sep; 35(38):e335. PubMed ID: 32989931
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Long-term follow-up of patients who received repeat-dose rituximab as maintenance therapy for ANCA-associated vasculitis.
    Alberici F; Smith RM; Jones RB; Roberts DM; Willcocks LC; Chaudhry A; Smith KG; Jayne DR
    Rheumatology (Oxford); 2015 Jul; 54(7):1153-60. PubMed ID: 25477054
    [TBL] [Abstract][Full Text] [Related]  

  • 38. World Workshop of Oral Medicine VII: A systematic review of immunobiologic therapy for oral manifestations of pemphigoid and pemphigus.
    Mays JW; Carey BP; Posey R; Gueiros LA; France K; Setterfield J; Woo SB; Sollecito TP; Culton D; Payne AS; Greenberg MS; De Rossi S
    Oral Dis; 2019 Jun; 25 Suppl 1(Suppl 1):111-121. PubMed ID: 31140696
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Treatment of ocular mucous membrane pemphigoid with immunosuppressive drug therapy.
    Thorne JE; Woreta FA; Jabs DA; Anhalt GJ
    Ophthalmology; 2008 Dec; 115(12):2146-2152.e1. PubMed ID: 18930554
    [TBL] [Abstract][Full Text] [Related]  

  • 40. New insights into immune mechanisms underlying response to Rituximab in patients with membranous nephropathy: A prospective study and a review of the literature.
    Roccatello D; Sciascia S; Di Simone D; Solfietti L; Naretto C; Fenoglio R; Baldovino S; Menegatti E
    Autoimmun Rev; 2016 Jun; 15(6):529-38. PubMed ID: 26876383
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.